# An Evaluation of the Spectra Optia CMNC Collection Procedure

> **NCT02253160** · NA · COMPLETED · sponsor: **Terumo BCT** · enrollment: 23 (actual)

## Conditions studied

- Healthy Apheresis Donors
- Mononuclear (MNC) Cell Donors

## Interventions

- **DEVICE:** Spectra Optia CMNC
- **DEVICE:** COBE Spectra MNC
- **DRUG:** Granulocyte-colony stimulating factor (G-CSF)

## Key facts

- **NCT ID:** NCT02253160
- **Lead sponsor:** Terumo BCT
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-09
- **Primary completion:** 2015-01
- **Final completion:** 2015-01
- **Target enrollment:** 23 (ACTUAL)
- **Last updated:** 2015-09-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02253160

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02253160, "An Evaluation of the Spectra Optia CMNC Collection Procedure". Retrieved via AI Analytics 2026-06-07 from https://api.ai-analytics.org/clinical/NCT02253160. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*